These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3375141)

  • 1. Prediction of time to progression after orchiectomy by the nuclear androgen receptor content from multiple biopsy specimens in patients with advanced prostate cancer.
    van Aubel O; Bolt-de Vries J; Blankenstein MA; Schröder FH
    Prostate; 1988; 12(3):191-8. PubMed ID: 3375141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear androgen receptor content in biopsy specimens from histologically normal, hyperplastic, and cancerous human prostatic tissue.
    van Aubel OG; Bolt-de Vries J; Blankenstein MA; ten Kate FJ; Schröder FH
    Prostate; 1985; 6(2):185-94. PubMed ID: 2579371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating testosterone, prostatic nuclear androgen receptor and time to progression in patients with metastatic disease of the prostate treated by orchiectomy.
    van Aubel OG; Bolt-de Vries J; Blankenstein MA; de Jong FH; Schröder FH
    Urol Res; 1989; 17(2):99-102. PubMed ID: 2734984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of nuclear androgen receptor quantification to human prostatic adenocarcinoma.
    Fentie DD; Lakey WH; McBlain WA
    J Urol; 1986 Jan; 135(1):167-73. PubMed ID: 3941459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptors in biopsy specimens of prostate adenocarcinoma. Heterogeneity of distribution and relation to prognostic significance of receptor measurements for survival of advanced cancer patients.
    Gorelic LS; Lamm DL; Ramzy I; Radwin HM; Shain SA
    Cancer; 1987 Jul; 60(2):211-9. PubMed ID: 3594358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer based receptogram approach: an objective way of assessing immunohistochemistry of androgen receptor staining and its correlation with hormonal response in metastatic carcinoma of prostate.
    Nabi G; Seth A; Dinda AK; Gupta NP
    J Clin Pathol; 2004 Feb; 57(2):146-50. PubMed ID: 14747438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease.
    Donovan MJ; Osman I; Khan FM; Vengrenyuk Y; Capodieci P; Koscuiszka M; Anand A; Cordon-Cardo C; Costa J; Scher HI
    BJU Int; 2010 Feb; 105(4):462-7. PubMed ID: 19624594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of prostatic nuclear androgen receptor content with duration of response and survival following hormonal therapy in advanced prostatic cancer.
    Trachtenberg J; Walsh PC
    J Urol; 1982 Mar; 127(3):466-71. PubMed ID: 7062420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor content of prostate carcinoma cells estimated by immunohistochemistry is related to prognosis of patients with stage D2 prostate carcinoma.
    Takeda H; Akakura K; Masai M; Akimoto S; Yatani R; Shimazaki J
    Cancer; 1996 Mar; 77(5):934-40. PubMed ID: 8608487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between androgen receptor binding activity in human prostate cancer and clinical response to endocrine therapy.
    Benson RC; Gorman PA; O'Brien PC; Holicky EL; Veneziale CM
    Cancer; 1987 May; 59(9):1599-606. PubMed ID: 3828960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.
    Palmberg C; Koivisto P; Kakkola L; Tammela TL; Kallioniemi OP; Visakorpi T
    J Urol; 2000 Dec; 164(6):1992-5. PubMed ID: 11061898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapy.
    Sadi MV; Barrack ER
    Cancer; 1993 Apr; 71(8):2574-80. PubMed ID: 7680949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy.
    Li R; Wheeler T; Dai H; Frolov A; Thompson T; Ayala G
    Am J Surg Pathol; 2004 Jul; 28(7):928-34. PubMed ID: 15223964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptors--a method to measure functional behaviour in human prostatic cancer.
    Kirkali Z; Moffat LE; Leake R; Cowan S; Patel M; Kirk D
    Eur Urol; 1990; 17(1):66-8. PubMed ID: 2318242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
    Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients.
    Noordzij MA; Bogdanowicz JF; van Krimpen C; van der Kwast TH; van Steenbrugge GJ
    J Urol; 1997 Nov; 158(5):1880-4; discussion 1884-5. PubMed ID: 9334622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of disease aggressivity in stage D2 prostate cancer patients (review).
    Koutsilieris M; Laroche B; Thabet M; Fradet Y
    Anticancer Res; 1990; 10(2A):333-6. PubMed ID: 2189359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy.
    Prins GS; Sklarew RJ; Pertschuk LP
    J Urol; 1998 Mar; 159(3):641-9. PubMed ID: 9474117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
    Sadi MV; Walsh PC; Barrack ER
    Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear androgen receptors in human prostatic tissue. Extraction with heparin and estimation of the number of binding sites with different methods.
    Foekens JA; Bolt-de Vries J; Mulder E; Blankenstein MA; Schröder FH; van der Molen HJ
    Clin Chim Acta; 1981 Jan; 109(1):91-102. PubMed ID: 7471492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.